Clinical Trials Logo
  1. Home
  2. Crohn's Disease (CD)
  3. NCT04271748

The Impact of Time Restricted Feeding in Crohn's Disease — TRF-CD  

Crohn's Disease (CD) Clinical Trial

Official title:
The Impact of Time Restricted Feeding in Crohn's Disease

Clinical Trial Summary

Time-restricted feeding (TRF) is a dietary regimen involving the consumption of food and liquids within a defined time window with or without additional restriction on dietary composition. TRF has been associated with improvements in inflammation, host metabolism, autophagy, gut microbial composition, and gut permeability. Crohn's disease is an inflammatory bowel disease of unknown etiology that likely results from a combination of genetic and environmental factors. This proposed study will test the hypothesis that a time-restricted feeding regimen will improve clinical outcomes and favorably influence the gut microbiome in patients with active Crohn's disease. If time-restricted fasting proves beneficial to this patient population then it will pave the way for larger, prospective studies and clinical trials.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04271748
Study type Interventional
Source Weill Medical College of Cornell University
Contact
Status Completed
Phase N/A
Start date January 14, 2021
Completion date November 1, 2022
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04524611 - Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) Phase 3
Completed NCT02778464 - Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
Terminated NCT02775656 - UCB Cimzia Pregnancy Follow-up Study
Active, not recruiting NCT02782663 - A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease Phase 2
Completed NCT02108821 - Fecal Microbiota Transplantation in Pediatric Patients Phase 1
Completed NCT04089514 - A Real-world Study of Imraldi® Use
Completed NCT01364896 - Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Completed NCT03801928 - Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
Recruiting NCT04779320 - A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Phase 3
Completed NCT01877577 - Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D N/A